Furthermore, our IHC staining results confirmed that PK5-RL-Gal-3C treatment could decrease the expression of HIF-1α in xenograft HCC tumor tissues in vivo (Fig. 4B and C). The gene discussed is GAL; the disease is hepatocellular carcinoma.